WHO ICTRP trial
Chondroitin sulphate for hand osteoarthritis: a randomised, placebo-controlled…
ISRCTN44644781 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN44644781 |
|---|---|
| Public title | Chondroitin sulphate for hand osteoarthritis: a randomised, placebo-controlled trial in primary care |
| Scientific title | Finger osteoArthritis Chondroitin Treatment Used in addition to Advice and Leaflets |
| Primary sponsor | Keele University |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | United Kingdom |
| Conditions | Osteoarthritis of the hand Musculoskeletal Diseases |
| Interventions | Participants are randomised to one of two treatment groups via a web-based database: 1. Highly purified chondroitin sulphate 1200mg (3 x 400mg capsules) daily, oral, taken once per day for 2 years; plus usual care 2. Matching placebo 1200mg… |
| Registration date | Nov 18, 2016 |
| Target size | 380 |
| Secondary IDs | 2016-004670-18;RG-0004-16-IPCHS; HTA 14/45/04 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: